Harriman G C, Abushanab E, Stoeckler J D
Department of Medicinal Chemistry, University of Rhode Island, Kingston 02881.
J Med Chem. 1994 Jan 21;37(2):305-8. doi: 10.1021/jm00028a014.
The synthesis of the title compound (15) and its 1'-fluoro (14) and 1'-hydroxy (12) derivatives is described. Key intermediate 10 was obtained by two routes through condensation of (2R,3R)-3-amino-1,2-O-isopropylidene-1,2-nonanediol (3) with either 2,4-dichloro- or 4-chloro-3-nitropyridine. When assayed as adenosine deaminase inhibitors, 15 was found to be almost twice as active as its racemate. While hydroxylation at the 1'-position resulted in an 80-fold decrease in activity, the 1'-fluoro derivative proved to have activity comparable to that of 3-deaza-(+)-EHNA.
本文描述了标题化合物(15)及其1'-氟代衍生物(14)和1'-羟基衍生物(12)的合成。关键中间体10可通过两条路线获得,即通过(2R,3R)-3-氨基-1,2-O-异丙叉基-1,2-壬二醇(3)与2,4-二氯-或4-氯-3-硝基吡啶缩合得到。当作为腺苷脱氨酶抑制剂进行测定时,发现15的活性几乎是其外消旋体的两倍。虽然在1'-位羟基化导致活性降低80倍,但1'-氟代衍生物的活性被证明与3-脱氮-(+)-EHNA相当。